Mark H. Gotfried

5.2k total citations
87 papers, 3.4k citations indexed

About

Mark H. Gotfried is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Mark H. Gotfried has authored 87 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 40 papers in Pulmonary and Respiratory Medicine and 35 papers in Pharmacology. Recurrent topics in Mark H. Gotfried's work include Pneumonia and Respiratory Infections (42 papers), Antibiotics Pharmacokinetics and Efficacy (34 papers) and Respiratory and Cough-Related Research (17 papers). Mark H. Gotfried is often cited by papers focused on Pneumonia and Respiratory Infections (42 papers), Antibiotics Pharmacokinetics and Efficacy (34 papers) and Respiratory and Cough-Related Research (17 papers). Mark H. Gotfried collaborates with scholars based in United States, Austria and United Kingdom. Mark H. Gotfried's co-authors include Keith A. Rodvold, Larry H. Danziger, Ronald J. Servi, Joan Korth‐Bradley, Evelyn J. Ellis‐Grosse, Gary Dukart, Mary Cwik, George L. Drusano, Brian Morrissey and Noreen Henig and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Mark H. Gotfried

82 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark H. Gotfried United States 34 1.4k 1.3k 1.2k 988 563 87 3.4k
D. Honeybourne United Kingdom 33 1.1k 0.8× 1.4k 1.1× 1.0k 0.9× 700 0.7× 311 0.6× 97 3.1k
Sandrine Marchand France 28 460 0.3× 758 0.6× 1.3k 1.1× 1.1k 1.1× 83 0.1× 116 2.5k
Charles Fogarty United States 21 743 0.5× 688 0.5× 328 0.3× 223 0.2× 552 1.0× 64 1.6k
Timothy Felton United Kingdom 20 296 0.2× 886 0.7× 759 0.6× 290 0.3× 139 0.2× 41 1.9k
Marc Lebel Canada 34 504 0.4× 1.6k 1.2× 886 0.8× 353 0.4× 89 0.2× 124 3.6k
Chris Stockmann United States 33 664 0.5× 1.5k 1.1× 561 0.5× 151 0.2× 107 0.2× 101 2.8k
A. Bruce Montgomery United States 28 3.7k 2.6× 1.3k 1.0× 232 0.2× 574 0.6× 528 0.9× 55 4.6k
Jerina Boelens Belgium 20 293 0.2× 734 0.6× 262 0.2× 181 0.2× 356 0.6× 83 1.8k
Harry Heijerman Netherlands 34 3.8k 2.7× 826 0.6× 340 0.3× 545 0.6× 385 0.7× 145 5.0k
Nicolas Grégoire France 24 317 0.2× 551 0.4× 808 0.7× 875 0.9× 60 0.1× 73 1.7k

Countries citing papers authored by Mark H. Gotfried

Since Specialization
Citations

This map shows the geographic impact of Mark H. Gotfried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Gotfried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Gotfried more than expected).

Fields of papers citing papers by Mark H. Gotfried

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Gotfried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Gotfried. The network helps show where Mark H. Gotfried may publish in the future.

Co-authorship network of co-authors of Mark H. Gotfried

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Gotfried. A scholar is included among the top collaborators of Mark H. Gotfried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Gotfried. Mark H. Gotfried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gotfried, Mark H., Sanford Auerbach, Thien Thanh Dang‐Vu, et al.. (2024). Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials. Drugs & Aging. 41(9). 741–752. 6 indexed citations
2.
Rosenberg, Russell, Michael J. Thorpy, Yves Dauvilliers, et al.. (2021). Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy. Journal of Clinical Sleep Medicine. 18(1). 235–244. 8 indexed citations
3.
Schweitzer, Paula K., Russell Rosenberg, Gary Zammit, et al.. (2018). Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 199(11). 1421–1431. 111 indexed citations
4.
Gotfried, Mark H., C Girod, Danielle Antin‐Ozerkis, et al.. (2018). An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002). Pulmonary Therapy. 4(1). 59–71. 2 indexed citations
5.
Bhattacharya, Indranil, et al.. (2013). Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures. The Journal of Clinical Pharmacology. 54(1). 70–74. 13 indexed citations
6.
Davenport, James M., Paul S. Covington, Mark H. Gotfried, et al.. (2012). Summary of Pharmacokinetics and Tissue Distribution of a Broad‐Spectrum Fluoroquinolone, JNJ‐Q2. Clinical Pharmacology in Drug Development. 1(4). 121–130. 11 indexed citations
7.
Chandorkar, Gurudatt, Jennifer A. Huntington, Mark H. Gotfried, Keith A. Rodvold, & Obiamiwe Umeh. (2012). Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects. Journal of Antimicrobial Chemotherapy. 67(10). 2463–2469. 106 indexed citations
8.
Herth, Felix, Peter Hopkins, Christian Witt, et al.. (2011). Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. European Respiratory Journal. 39(6). 1326–1333. 99 indexed citations
9.
Herth, Felix, Peter Hopkins, Christian Witt, et al.. (2011). Sustained efficacy from 3 to 6 months following bronchoscopic thermal vapor ablation (BTVA) in the treatment of heterogeneous emphysema. European Respiratory Journal. 38(Suppl 55). 370–370. 1 indexed citations
10.
Albertson, Timothy E., et al.. (2010). Fluoroquinolones in the management of community-acquired pneumonia. International Journal of Clinical Practice. 64(3). 378–388. 23 indexed citations
11.
Criner, Gerard J., Víctor Pinto-Plata, Charlie Strange, et al.. (2009). Biologic Lung Volume Reduction in Advanced Upper Lobe Emphysema: Phase 2 Results. American Journal of Respiratory and Critical Care Medicine. 179(9). 791–798. 73 indexed citations
12.
Gotfried, Mark H., Rose Jung, Chad R. Messick, et al.. (2004). Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot study. Current Therapeutic Research. 65(1). 1–12. 17 indexed citations
13.
Gotfried, Mark H.. (2004). Appropriate Outpatient Macrolide Use in Community‐Acquired Pneumonia. Journal of the American Academy of Nurse Practitioners. 16(4). 146–156. 3 indexed citations
14.
Gotfried, Mark H.. (2003). Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects. Journal of Antimicrobial Chemotherapy. 52(3). 450–456. 24 indexed citations
15.
16.
Gotfried, Mark H., et al.. (2002). Development and implementation of the Clinical Privileges for Dietitian Nutrition Order Writing Program at a long-term acute-care hospital. Journal of the American Dietetic Association. 102(1). 72–81. 17 indexed citations
17.
18.
Barker, Alan F., Stanley B. Fiel, Mark H. Gotfried, et al.. (2000). Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 162(2). 481–485. 239 indexed citations
19.
Gotfried, Mark H. & Collin D. Freeman. (2000). An update on community-acquired pneumonia in adults. Comprehensive Therapy. 26(4). 283–293. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Honeybourne Breakdown of academic impact, for papers by Sandrine Marchand Breakdown of academic impact, for papers by Charles Fogarty Breakdown of academic impact, for papers by Timothy Felton Breakdown of academic impact, for papers by Marc Lebel Breakdown of academic impact, for papers by Chris Stockmann Breakdown of academic impact, for papers by A. Bruce Montgomery Breakdown of academic impact, for papers by Jerina Boelens Breakdown of academic impact, for papers by Harry Heijerman Breakdown of academic impact, for papers by Nicolas Grégoire
Rankless by CCL
2026